ARBINOXA ORAL SOLUTION Rx
Generic Name and Formulations:
Carbinoxamine maleate 4mg/5mL; bubble gum flavor.
Indications for ARBINOXA ORAL SOLUTION:
Allergic (seasonal and perennial) and vasomotor rhinitis, conjunctivitis, urticaria, angioedema, reactions to blood. Adjunct in anaphylaxis. Dermatographism.
4–8mg 3–4 times daily.
<2yrs: contraindicated. 2–5yrs: 0.2–0.4mg/kg/day in 3–4 divided doses. 6–11yrs: 2–4mg 3–4 times daily.
Children <2yrs old. Concomitant MAOIs. Nursing mothers.
Not for treating lower respiratory tract symptoms, including asthma. Narrow angle glaucoma. Peptic ulcer. GI or GU obstruction. Increased intraocular pressure. Hyperthyroidism. Cardiovascular disease. Hypertension. Elderly. Pregnancy (Cat.C).
CNS depression potentiated by alcohol (avoid), other CNS depressants. MAOIs potentiate anticholinergic effects.
Sedation, sleepiness, dizziness, disturbed coordination, GI upset, thickening of bronchial secretions, anticholinergic effects, excitability in children.
Tabs—100; Oral soln—16oz
- Recall of Two IV Antibiotics Announced
- Five Things ID Experts Want You to Know Before You Prescribe an Antibiotic
- What's Changed in Immunization Recommendations From CDC Advisory Committee
- IUD Approval Gives Women New Long-Acting Birth Control Option
- Vitamin D: Greater Risk Factor for Diabetes Than Weight?
- Number of Docs, Retail Clinics Affect Antibiotic Prescribing Rate
- More Evidence Points to the Power of Nuts in Reducing CVD Mortality
- Overactive Bladder Drug May be Beneficial in MS
- FDA to Review Investigational Parkinson's Disease Drug Xadago
- How Prevalent is Antipsychotic Prescribing in Seniors with Dementia?